Nifty

:

24213.30

Sensex

:

79476.63

217.95 (0.91%)
694.39 (0.88%)

Login

Nifty
Sensex

:
:

24213.30
79476.63

217.95 (0.91%)
694.39 (0.88%)

Balaxi Pharmaceuticals Ltd.

Finance - Investment

Rating :

N/A

BSE: Not Listed | NSE: BALAXI

Watchlist

NSE BSE

118.37

05-Jul-2024

Open
High
Low
Previous Close

120.10
120.99
117.00
119.51

Volume
Traded Value (lacs)
52 Week High
52 Week Low

17972
21.41
151.45
80.22

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

487.59
10.73
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

442.96
N/A
2.32

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

89.11
39.53
-4.77

EBITDA CAGR (%)

10 Years
5 Years
3 Years

63.20
40.11
-2.61

PAT CAGR (%)

10 Years
5 Years
3 Years

43.29
-10.90
-37.10

P:E (Median)

8 Years
5 Years
3 Years

-
-
10.10

P:BV (Average)

8 Years
5 Years
3 Years

-
-
3.73

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
10.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 19.03 25.04 -24.00% 15.91 30.35 -47.58% 12.70 23.07 -44.95% 16.55 28.26 -41.44%
Expenses 17.52 21.27 -17.63% 15.71 24.96 -37.06% 12.42 19.50 -36.31% 15.64 24.74 -36.78%
EBITDA 1.51 3.77 -59.95% 0.20 5.39 -96.29% 0.28 3.56 -92.13% 0.91 3.53 -74.22%
EBIDTM 7.94% 15.06% 1.25% 17.77% 2.20% 15.45% 5.51% 12.47%
Other Income 0.85 0.13 553.85% 0.16 0.18 -11.11% 1.03 1.35 -23.70% 1.15 2.50 -54.00%
Interest 0.35 0.26 34.62% 0.51 0.22 131.82% 0.41 0.01 4,000.00% 0.36 0.02 1,700.00%
Depreciation 0.12 0.13 -7.69% 0.12 0.27 -55.56% 0.13 0.08 62.50% 0.13 0.08 62.50%
PBT 1.89 3.51 -46.15% -0.26 5.09 - 0.77 4.81 -83.99% 1.57 5.92 -73.48%
Tax 0.51 0.95 -46.32% 0.31 1.15 -73.04% 0.28 1.28 -78.12% 0.39 1.95 -80.00%
PAT 1.38 2.55 -45.88% -0.57 3.94 - 0.49 3.53 -86.12% 1.18 3.98 -70.35%
PATM 7.23% 10.20% -3.62% 12.99% 3.84% 15.31% 7.14% 14.07%
EPS 0.25 0.46 -45.65% -0.10 0.71 - 0.09 0.64 -85.94% 0.21 0.72 -70.83%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 65.62 65.95 -0.50% 59.83 80.68 -25.84% 60.79 86.58 -29.79% 54.72 86.39 -36.66%
Expenses 55.54 57.11 -2.75% 46.37 67.94 -31.75% 47.13 71.29 -33.89% 43.96 71.63 -38.63%
EBITDA 10.09 8.84 14.14% 13.47 12.74 5.73% 13.66 15.29 -10.66% 10.76 14.75 -27.05%
EBIDTM 15.37% 13.40% 22.51% 15.79% 22.47% 17.66% 19.67% 17.08%
Other Income -1.85 -1.01 - -1.79 -0.22 - -0.13 -4.56 - 0.28 4.14 -93.24%
Interest 0.37 0.29 27.59% 0.61 0.27 125.93% 0.42 0.01 4,100.00% 0.37 0.02 1,750.00%
Depreciation 0.49 0.29 68.97% 0.67 1.19 -43.70% 0.48 0.19 152.63% 0.66 0.19 247.37%
PBT 7.38 -39.41 - 11.49 11.07 3.79% 14.27 10.53 35.52% 15.66 18.68 -16.17%
Tax 0.89 1.93 -53.89% 0.56 2.97 -81.14% 0.68 2.30 -70.43% 1.23 3.19 -61.44%
PAT 6.48 -41.34 - 10.93 8.10 34.94% 13.59 8.23 65.13% 14.43 15.49 -6.84%
PATM 9.87% -62.68% 18.27% 10.04% 22.36% 9.50% 26.37% 17.93%
EPS 1.17 -8.08 - 2.01 1.59 26.42% 2.66 1.64 62.20% 2.82 3.10 -9.03%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 64.19 70.20 108.14 101.29 86.87 45.63 13.60 0.00 0.00 0.05 0.12 Net Sales Growth -39.85% -35.08% 6.76% 16.60% 90.38% 235.51% 0 0 -100% -58.33% Cost Of Goods Sold 53.12 56.49 82.10 76.92 63.33 32.83 10.24 0.00 0.00 0.00 0.00 Gross Profit 11.07 13.71 26.04 24.37 23.54 12.81 3.36 0.00 0.00 0.05 0.12 GP Margin 17.25% 19.53% 24.08% 24.06% 27.10% 28.07% 24.71% 0 0 100% 100% Total Expenditure 61.29 64.84 91.27 83.99 67.85 36.99 12.04 0.77 0.13 0.12 0.08 Power & Fuel Cost - 0.04 0.04 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.06% 0.04% 0.02% 0% 0% 0% 0 0 0% 0% Employee Cost - 5.04 4.04 2.90 1.95 1.75 0.90 0.15 0.07 0.06 0.02 % Of Sales - 7.18% 3.74% 2.86% 2.24% 3.84% 6.62% 0 0 120.0% 16.67% Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0 0 0% 0% General & Admin Exp. - 2.62 4.54 3.51 2.11 2.29 0.61 0.59 0.06 0.06 0.04 % Of Sales - 3.73% 4.20% 3.47% 2.43% 5.02% 4.49% 0 0 120.0% 33.33% Selling & Distn. Exp. - 0.13 0.21 0.40 0.07 0.10 0.21 0.03 0.00 0.00 0.01 % Of Sales - 0.19% 0.19% 0.39% 0.08% 0.22% 1.54% 0 0 0% 8.33% Miscellaneous Exp. - 0.52 0.35 0.24 0.39 0.02 0.08 0.00 0.00 0.00 0.01 % Of Sales - 0.74% 0.32% 0.24% 0.45% 0.04% 0.59% 0 0 0% 8.33% EBITDA 2.90 5.36 16.87 17.30 19.02 8.64 1.56 -0.77 -0.13 -0.07 0.04 EBITDA Margin 4.52% 7.64% 15.60% 17.08% 21.89% 18.93% 11.47% 0 0 -140.0% 33.33% Other Income 3.19 2.40 6.60 2.75 1.81 0.59 0.89 0.00 0.00 0.00 0.12 Interest 1.63 1.66 0.51 0.10 0.15 0.05 0.00 0.00 0.04 0.05 0.01 Depreciation 0.50 0.51 0.52 0.25 0.09 0.01 0.00 0.00 0.00 0.00 0.00 PBT 3.97 5.58 22.45 19.70 20.60 9.19 2.44 -0.77 -0.17 -0.12 0.15 Tax 1.49 1.93 6.23 5.03 5.46 2.69 0.47 0.00 0.00 -0.04 0.04 Tax Rate 37.53% 34.59% 27.75% 25.53% 26.50% 29.27% 19.26% 0.00% 0.00% 33.33% 26.67% PAT 2.48 3.65 16.22 14.67 15.13 6.50 1.97 -0.77 -0.17 -0.08 0.10 PAT before Minority Interest 2.48 3.65 16.22 14.67 15.13 6.50 1.97 -0.77 -0.17 -0.08 0.10 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.86% 5.20% 15.00% 14.48% 17.42% 14.25% 14.49% 0 0 -160.0% 83.33% PAT Growth -82.29% -77.50% 10.57% -3.04% 132.77% 229.95% - - - - EPS 0.45 0.66 2.94 2.66 2.74 1.18 0.36 -0.14 -0.03 -0.01 0.02

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 240.96 241.29 336.43 279.39 231.33 45.63 13.60 Net Sales Growth -24.61% -28.28% 20.42% 20.78% 406.97% 235.51% Cost Of Goods Sold 126.50 128.68 202.42 195.60 172.15 32.83 10.24 Gross Profit 114.46 112.61 134.02 83.79 59.19 12.81 3.36 GP Margin 47.50% 46.67% 39.84% 29.99% 25.59% 28.07% 24.71% Total Expenditure 193.00 196.75 279.02 228.56 188.66 37.38 12.04 Power & Fuel Cost - 0.04 0.28 0.35 0.00 0.00 0.00 % Of Sales - 0.02% 0.08% 0.13% 0% 0% 0% Employee Cost - 28.04 28.95 12.47 8.47 2.10 0.90 % Of Sales - 11.62% 8.61% 4.46% 3.66% 4.60% 6.62% Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% General & Admin Exp. - 24.17 35.00 14.98 5.28 2.34 0.61 % Of Sales - 10.02% 10.40% 5.36% 2.28% 5.13% 4.49% Selling & Distn. Exp. - 0.66 0.84 1.02 0.10 0.10 0.21 % Of Sales - 0.27% 0.25% 0.37% 0.04% 0.22% 1.54% Miscellaneous Exp. - 15.17 11.52 4.16 2.65 0.02 0.08 % Of Sales - 6.29% 3.42% 1.49% 1.15% 0.04% 0.59% EBITDA 47.98 44.54 57.41 50.83 42.67 8.25 1.56 EBITDA Margin 19.91% 18.46% 17.06% 18.19% 18.45% 18.08% 11.47% Other Income -3.49 0.63 2.64 4.97 2.23 0.59 0.89 Interest 1.77 2.77 1.38 0.76 0.28 0.05 0.00 Depreciation 2.30 2.10 1.75 0.51 0.30 0.01 0.00 PBT 48.80 40.31 56.92 54.52 44.33 8.79 2.44 Tax 3.36 4.40 10.96 6.86 6.19 2.69 0.47 Tax Rate 6.89% 217.82% 19.26% 12.58% 13.96% 30.60% 19.26% PAT 45.43 -2.39 45.96 47.66 38.14 6.10 1.97 PAT before Minority Interest 45.43 -2.39 45.96 47.66 38.14 6.10 1.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.85% -0.99% 13.66% 17.06% 16.49% 13.37% 14.49% PAT Growth 577.21% - -3.57% 24.96% 525.25% 209.64% EPS 8.23 -0.43 8.33 8.63 6.91 1.11 0.36

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 121.55 92.11 57.91 43.25 28.11 3.52 1.55 2.32 3.15 3.22 Share Capital 10.90 10.18 10.00 10.00 10.00 3.04 3.04 3.04 3.04 3.04 Total Reserves 106.88 71.63 47.91 33.25 18.11 0.48 -1.49 -0.72 0.11 0.18 Non-Current Liabilities 2.78 2.79 0.04 0.01 0.00 0.00 0.00 0.00 -0.04 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 30.04 34.83 23.96 25.67 9.79 2.59 0.13 0.05 0.42 0.46 Trade Payables 12.44 17.26 15.75 16.64 6.91 2.08 0.09 0.00 0.00 0.13 Other Current Liabilities 2.17 2.31 1.54 0.08 0.46 0.04 0.03 0.03 0.03 0.03 Short Term Borrowings 13.96 10.75 1.93 3.51 0.00 0.00 0.00 0.00 0.20 0.00 Short Term Provisions 1.47 4.51 4.75 5.44 2.41 0.47 0.01 0.01 0.18 0.30 Total Liabilities 154.37 129.73 81.91 68.93 37.90 6.11 1.68 2.37 3.53 3.68 Net Block 7.10 7.89 2.20 0.69 0.19 0.01 0.01 0.00 0.00 0.00 Gross Block 7.61 8.75 2.54 0.78 0.19 0.01 0.01 0.00 0.01 0.01 Accumulated Depreciation 0.51 0.85 0.34 0.09 0.00 0.00 0.00 0.00 0.01 0.01 Non Current Assets 31.46 30.70 27.84 20.25 1.21 0.33 0.04 0.03 3.28 3.42 Capital Work in Progress 2.31 2.83 0.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 19.88 19.54 19.61 19.54 0.10 0.00 0.00 0.00 3.27 3.42 Long Term Loans & Adv. 1.78 0.04 0.59 0.02 0.92 0.32 0.03 0.03 0.00 0.00 Other Non Current Assets 0.40 0.40 4.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 122.90 99.02 54.08 48.67 36.70 5.78 1.65 2.34 0.26 0.26 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 Inventories 0.84 1.49 0.00 0.02 0.83 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 76.76 78.29 52.11 48.13 31.22 5.47 0.00 0.00 0.00 0.01 Cash & Bank 44.06 17.88 0.84 0.48 3.57 0.13 1.65 2.34 0.01 0.02 Other Current Assets 1.24 0.74 0.75 0.00 1.08 0.17 0.00 0.00 0.23 0.23 Short Term Loans & Adv. 0.52 0.62 0.37 0.05 1.08 0.17 0.00 0.00 0.20 0.20 Net Current Assets 92.86 64.19 30.11 23.00 26.91 3.19 1.51 2.29 -0.16 -0.19 Total Assets 154.36 129.72 81.92 68.92 37.91 6.11 1.69 2.37 3.54 3.68

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 201.36 182.88 113.16 64.98 27.75 3.52 Share Capital 10.90 10.18 10.00 10.00 10.00 3.04 Total Reserves 186.69 162.40 103.16 54.98 17.75 0.48 Non-Current Liabilities 2.78 3.66 0.04 0.01 0.00 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.87 0.00 0.00 0.00 0.00 Long Term Provisions 0.04 0.00 0.00 0.00 0.00 0.00 Current Liabilities 54.20 53.13 63.27 34.69 8.22 2.59 Trade Payables 29.04 34.52 49.11 24.88 4.85 2.08 Other Current Liabilities 4.62 2.81 3.26 0.14 0.96 0.04 Short Term Borrowings 17.66 10.75 3.64 3.66 0.00 0.00 Short Term Provisions 2.88 5.06 7.25 6.01 2.42 0.47 Total Liabilities 258.34 239.67 176.47 99.68 35.97 6.11 Net Block 40.88 41.41 28.76 2.45 0.19 0.01 Gross Block 42.98 43.76 29.51 2.75 0.19 0.01 Accumulated Depreciation 2.10 2.35 0.76 0.30 0.00 0.00 Non Current Assets 48.17 46.16 35.47 5.91 1.11 0.33 Capital Work in Progress 2.31 2.83 0.57 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 3.42 0.00 0.00 Long Term Loans & Adv. 4.58 1.52 1.27 0.05 0.92 0.32 Other Non Current Assets 0.40 0.40 4.87 0.00 0.00 0.00 Current Assets 210.17 193.51 141.00 93.77 34.86 5.78 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 82.17 105.02 98.70 13.62 0.83 0.00 Sundry Debtors 55.71 52.28 27.56 76.76 29.71 5.47 Cash & Bank 62.29 28.22 7.19 1.67 4.00 0.13 Other Current Assets 10.01 3.78 3.90 0.77 0.31 0.17 Short Term Loans & Adv. 7.99 4.21 3.65 0.95 0.31 0.17 Net Current Assets 155.97 140.38 77.74 59.08 26.64 3.19 Total Assets 258.34 239.67 176.47 99.68 35.97 6.11

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -1.83 -7.07 8.89 13.46 -14.37 -1.51 -0.68 -0.13 -0.03 0.21 PBT 5.58 22.45 19.70 20.60 9.19 2.44 -0.77 -0.17 -0.12 0.15 Adjustment 2.05 0.97 0.31 0.10 0.01 0.00 0.00 0.04 0.00 -0.12 Changes in Working Capital -4.39 -25.08 -5.44 -4.80 -22.82 -3.94 0.09 0.00 0.08 0.25 Cash after chg. in Working capital 3.24 -1.66 14.57 15.90 -13.63 -1.50 -0.68 -0.13 -0.03 0.28 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.08 -5.41 -5.69 -2.44 -0.74 -0.01 0.00 0.00 0.00 -0.07 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.46 -2.29 -6.87 -20.03 -0.28 -0.01 -0.01 2.67 0.13 -3.11 Net Fixed Assets 1.66 -8.47 -2.33 -0.59 -0.18 0.00 -0.01 0.01 0.00 0.00 Net Investments -0.34 0.07 -0.07 -19.44 -0.10 0.00 0.00 3.28 0.14 -3.23 Others -0.86 6.11 -4.47 0.00 0.00 -0.01 0.00 -0.62 -0.01 0.12 Cash from Financing Activity 27.55 26.39 -1.64 3.49 18.10 0.00 0.00 -0.24 -0.11 2.38 Net Cash Inflow / Outflow 26.19 17.03 0.38 -3.08 3.44 -1.51 -0.69 2.30 -0.02 -0.52 Opening Cash & Equivalents 17.87 0.84 0.47 3.55 0.10 1.62 2.30 0.01 0.02 0.55 Closing Cash & Equivalent 44.06 17.87 0.84 0.47 3.55 0.10 1.62 2.30 0.01 0.02

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 4.87 6.08 34.14 0.00 -14.04 -1.51 PBT 2.02 56.92 54.52 44.33 8.79 2.44 Adjustment -1.14 8.03 1.18 -0.59 0.03 0.00 Changes in Working Capital 10.68 -46.79 -15.97 -41.14 -22.12 -3.94 Cash after chg. in Working capital 11.55 18.17 39.74 2.60 -13.29 -1.50 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -6.68 -12.09 -5.59 -2.59 -0.74 -0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.05 -10.57 -28.45 -5.97 -0.18 -0.01 Net Fixed Assets 1.66 -8.47 -2.33 -0.59 -0.18 Net Investments -0.34 0.07 -0.07 -19.44 -0.10 Others -2.37 -2.17 -26.05 14.06 0.10 Cash from Financing Activity 30.25 25.51 -0.16 3.65 18.10 0.00 Net Cash Inflow / Outflow 34.07 21.02 5.53 -2.32 3.88 -1.51 Opening Cash & Equivalents 28.21 7.19 1.66 3.98 0.10 1.62 Closing Cash & Equivalent 62.29 28.21 7.19 1.66 3.98 0.10

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 21.61 16.07 57.91 43.25 28.11 11.58 5.11 7.65 10.36 10.61 ROA 2.57% 15.33% 19.45% 28.33% 29.52% 50.44% -37.96% -5.90% -2.23% 4.19% ROE 3.66% 23.22% 29.00% 42.42% 41.07% 77.47% -39.69% -6.37% -2.52% 5.11% ROCE 6.08% 28.22% 37.14% 55.42% 58.38% 96.22% -39.69% -4.69% -2.11% 7.68% Fixed Asset Turnover 8.58 19.16 61.00 179.45 461.17 1311.03 0.00 0.00 3.76 13.39 Receivable days 403.10 220.07 180.60 166.70 146.76 146.96 0.00 0.00 34.59 435.99 Inventory Days 6.07 5.05 0.00 1.78 6.66 0.00 0.00 0.00 0.00 0.00 Payable days 95.97 73.37 76.85 67.89 50.00 34.94 101.81 23.21 0.00 688.54 Cash Conversion Cycle 313.20 151.74 103.75 100.59 103.42 112.02 -101.81 -23.21 34.59 -252.55 Total Debt/Equity 0.12 0.13 0.03 0.08 0.00 0.00 0.00 0.00 0.06 0.00 Interest Cover 4.36 45.29 203.45 140.54 196.86 1061.57 0.00 -3.23 -1.48 11.74

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 36.26 33.90 113.16 64.98 27.75 11.58 ROA -0.96% 22.09% 34.52% 56.23% 29.01% 32.19% ROE -1.29% 32.17% 53.50% 82.26% 39.04% 55.84% ROCE 2.31% 37.46% 59.62% 92.56% 56.56% 69.35% Fixed Asset Turnover 5.56 9.18 17.32 157.71 461.40 1203.13 Receivable days 81.67 43.31 68.14 84.00 140.73 146.96 Inventory Days 141.58 110.51 73.37 11.40 6.66 0.00 Payable days 90.14 75.41 69.04 31.52 38.51 66.84 Cash Conversion Cycle 133.11 78.42 72.47 63.88 108.88 80.12 Total Debt/Equity 0.09 0.07 0.03 0.06 0.00 0.00 Interest Cover 1.73 42.34 72.69 160.34 184.97 1061.57

Top Investors:

elara india opportunities fund limited

mgc fund limited

rajasthan global securities private limited

kunal mahendra bhakta

amol anand mantri

investor education and protection fund (iepf)

Annual Reports:

News Update:

Balaxi Pharma. - Quarterly Results
2nd Aug 2024, 12:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback